Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Ranibizumab (Ongavia) 10 mg/ml solution for injection {equilateral_black_triangle}

Active Ingredient:
ranibizumab
Company:  
Teva UK Limited See contact details
ATC code: 
S01LA04
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) HCP Med Info
{arrow_left}
{arrow_right}
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 30 Aug 2023

{equilateral_black_triangle} This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.

{pdf} View or print the patient leaflet as PDF
Teva UK Limited
Company image
Address
Field House, Station Approach, Harlow, Essex, CM20 2FB
Telephone
+44 (0)207 540 7000
Medical Information Direct Line
+44 (0)207 540 7117
Medical Information Fax
+44 (0) 207 000 1216
Medical Information e-mail
[email protected]
Stock Availability
0800 590 502
WWW
www.tevauk.com